
In 2019, approximately 2,100 deaths in Ghana were attributed to antimicrobial resistance (AMR), a trend that highlights a significant and growing public health threat. Dr. Benjamin Kissi Sasu, Deputy Head of the National Food Safety Laboratory, disclosed these figures during a stakeholder meeting where he emphasized the urgent need for a coordinated response. The data underscores the danger of drug-resistant bacteria, which complicates the treatment of common infections and increases mortality rates across the country.
The findings were presented following a field assessment that scrutinized the food production chain, specifically engaging with farmers in the Greater Accra Region. Dr. Sasu pointed out that improper antibiotic use in animal production is a major contributor to food contamination. When livestock are administered antimicrobials inappropriately, resistant bacteria can enter the food supply, posing a direct risk to consumers. This misuse not only compromises individual health but also weakens the effectiveness of life-saving medicines on a national scale.
The situation in Ghana mirrors a worrying global trend where AMR is projected to cause 10 million deaths annually by 2050. Projections indicate that more than 25 percent of these fatalities will occur in Africa if current usage patterns are not reversed. To combat this, Dr. Sasu called for intensive collaboration among all stakeholders within the agriculture and food value chains. He emphasized that promoting responsible antimicrobial usage is essential to safeguard both the national economy and public health.
Efforts to mitigate these risks are currently being bolstered by international cooperation, including the UK government’s Tackling Deadly Diseases in Africa Programme II. This initiative aims to strengthen Ghana’s national response to AMR by improving surveillance and laboratory capacity. By addressing the root causes of resistance in the agricultural sector and enhancing food safety protocols, health officials hope to reduce the death toll and ensure that medications remain effective for future generations.